Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.

MDT, RSMDF, WAT
Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.

NEW YORK, February 21, 2013 /PRNewswire/ --

Today, National Traders Association announced new research reports highlighting ResMed Inc. (NYSE: RMD), Zimmer Holdings, Inc. (NYSE: ZMH), Waters Corporation (NYSE: WAT), Covidien PLC (NYSE: COV), and Medtronic, Inc. (NYSE: MDT). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

ResMed Inc. Research Report

ResMed is a world leader in the development, manufacturing, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.  The company has just posted a quarter ended December 31, 2012 revenue of $376.5 million, a 13% increase over the previous year. A strong year-over-year growth in both top and bottom lines also increased revenues locally and abroad. The Full Research Report on ResMed Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.nationaltradersassociation.org/r/full_research_report/a31b_RMD]

--

Zimmer Holdings, Inc. Research Report

Global leader in musculoskeletal health, Zimmer Holdings, Inc., has recently launched the V2F Anterior Fixation System- a new implant system for the treatment of tumors, thoracolumbar burst fractures, disc degeneration and other pathologies of the anterior spine. This is Zimmer's first lateral plate system for the spinal trauma segment. The V2F system offers surgeons greater flexibility to address the unique anatomy of every patient. The Full Research Report on Zimmer Holdings, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.nationaltradersassociation.org/r/full_research_report/cad9_ZMH]

--

Waters Corporation Research Report

Analytic instruments manufacturer, Waters Corporation has done it again as it introduces new peptide separations chromatography columns, the ACQUITY UPLC, CSH130 C18 and XSelect HPLC . These new series of UltraPerformance LC (UPLC) and high performance liquid chromatography are set to uphold a new standard in the analysis and purification of peptides. The Full Research Report on Waters Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.nationaltradersassociation.org/r/full_research_report/9a02_WAT]

--

Covidien PLC Research Report

Covidien PLC is off to a great start this fiscal 2013, according to Jose E. Almeida, Chairman, President and CEO.  "In our large Medical Devices segment, we continued to generate above-market growth in a number of key categories, including stapling, energy, airway and ventilation. We delivered very strong growth in emerging markets, as we realized the benefits of our recent substantial investments in these fast-growing regions." Covidien's net sales are up 5%, with medical devices sales up 8%. It has also announced completed acquisition of CV Ingenuity. The Full Research Report on  Covidien PLC - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.nationaltradersassociation.org/r/full_research_report/788a_COV]

--

Medtronic Inc. Research Report

Despite weakness in the U.S. and Europe, Medtronic marks up a 5.7% earnings growth, with revenues from emerging markets up by 20%. The company looks to expand sales in countries like China, as the more-developed nations cut back on expensive medical procedures because of tight budgets. The company recently spent $816 million for the acquisition of China Kanghui Holdings, a manufacturer of spine and joint reconstruction products. The Full Research Report on Medtronic Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.nationaltradersassociation.org/r/full_research_report/1a9b_MDT]

--

Consider National Traders Association

Tired of hearing about the latest, greatest trade opportunity... only to realize that the ship has long sailed? You need a strong, informative community in your arsenal. Join the group that has been consistently identifying momentous situations as they develop - long before they become the next top news on major financial networks.

Contact: Demi Lapierre
Email: press@NationalTradersAssociation.org
Main: +1-(702)-212-4493


SOURCE National Traders Association